Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3Tumor-Agnostic 1Genitourinary 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Advanced or Recurrent Solid Tumors 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × vadimezan × Other solid neoplasm × Clear all
NCT01285453 2020-12-09

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Novartis

Phase 1 Completed
9 enrolled
Other solid neoplasm

Advanced or Recurrent Solid Tumors

NCT00003697 2013-12-19

Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00863733 2009-03-18

DMXAA

Cancer Research UK

Phase 1 Completed
63 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡